Target intelligence / Profile preview

Gram-negative bacterial inner membrane and cytoplasmic contents

Molecular classification
Enzyme, Transporter, Receptor, Other
01

Overview

The Gram-negative bacterial inner membrane and cytoplasmic contents represent the essential internal environment of the bacterium, encompassing the cytoplasmic membrane and the intracellular machinery required for life (Sohlenkamp & Geiger, 2016). The inner membrane is a phospholipid bilayer that serves as a selective permeability barrier and the site of the electron transport chain and ATP synthesis (Silhavy et al., 2010). Within the cytoplasm, the target includes the bacterial genome, 70S ribosomes, and various enzymes involved in metabolic pathways (Blair et al., 2015). Antibiotics such as polymyxins target the inner membrane to cause leakage of cytoplasmic contents, leading to cell death (Trimble et al., 2016). Other classes, including aminoglycosides and fluoroquinolones, must penetrate this membrane to reach their respective targets, the ribosome and DNA gyrase, to inhibit protein synthesis and DNA replication (Lewis, 2013). This broad categorization is typically viewed as a collection of multiple distinct therapeutic targets rather than a single molecular entity.

Other names
Bacterial inner membraneBacterial cytoplasmic membraneBacterial cytoplasmGram-negative bacterial protoplast
02

Mechanism of action

Disruption of the inner membrane phospholipid bilayer, inhibition of the 30S or 50S ribosomal subunits to block protein synthesis, and inhibition of DNA gyrase or topoisomerase IV to prevent DNA replication (Blair et al., 2015; Trimble et al., 2016).

03

Biological functions

Cell cycleCell deathOther
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityNeurotoxicityDevelopment of antimicrobial resistanceOff-target effects on host mitochondrial membranes
06

Interacting drugs

Colistin

5 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Bacterial loadProcalcitonin

Beyond the preview

Go deeper on Gram-negative bacterial inner membrane and cytoplasmic contents.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial inner membrane and cytoplasmic contents.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call